A better way to make RNA drugs: Enzymatic synthesis method expands capabilities while eliminating toxic byproducts

While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and amyloidosis. RNA therapies offer many advantages over tra